简介：【摘要】目的 探索糖尿病伴高血脂症患者服药瑞舒伐他汀联合盐酸二甲双胍治疗的效果。方法 74例糖尿病伴高血脂症患者，均于2018年3月-2020年12月就诊，将患者随机数字表法分组，每组有37例，对照组盐酸二甲双胍药物治疗，观察组在对照组基础上联合瑞舒伐他汀，分析效果。结果 在治疗前，两组患者对比指标数据差异不明显，治疗后，观察组空腹血糖、餐后2小时血糖以及血脂指标低于对照组，有统计学意义（P

简介：      【摘要】目的：观察和探究盐酸达克罗宁胶浆润滑尿道及导尿管在减少男性全麻患者留置导尿后麻醉恢复期躁动的应用效果。

简介：　　 [摘要 ] 目的 探讨美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎的疗效及其对炎性因子的影响。 方法 选取 2018年 1月～ 2020年 1月我院收治的溃疡性结肠炎患者 80例，随机分为两组，每组各 40例，两组患者均予常规对症治疗，同时两组均予美沙拉嗪缓释颗粒，观察组同时加用双歧三联活菌胶囊，治疗后比较两组患者治疗后的临床疗效，以及两组患者治疗前后 TNF-α、 IL-10水平的变化情况及两组患者治疗前后的临床症状积分变化情况。结果 观察组治疗后的总有效率为 95.00%，显著高于对照组的总有效率 70.00%，两组疗效比较差异具有显著性（ P<0.05）。治疗后，两组患者的炎性因子 TNF-α、 IL-10水平较治疗前显著降低（ P<0.05）。且观察组患者治疗后的 TNF-α、 IL-10水平显著低于对照组（ P<0.05）。观察组患者治疗后的临床症状积分为（ 2.56±0.85）分，与治疗前及对照组比较，差异有统计学意义（ P<0.05）。 结论 美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎疗效确切，且可以抑制炎症反应，值得临床推广和应用。  　　 [关键词 ] 溃疡性结肠炎 ;美沙拉嗪 ;双歧三联活菌 ;炎性因子  　 [Abstract] Objective To investigate the efficacy of mesalazine combined with Bifid Triple Viable Bacteria in the treatment of ulcerative colitis and its influence on inflammatory factors. method Methods: 80 patients with ulcerative colitis in our hospital from January 2018 to January 2020 were selected and randomly divided into two groups, 40 cases in each group. Both groups were given conventional symptomatic treatment, while the two groups were given mesalazine sustained-release granules. The observation group was also given Bifid Triple Viable capsules. After treatment, the clinical efficacy of the two groups of patients after treatment, as well as TNF - α, IL-10 water before and after treatment, were compared between the two groups The changes of the two groups of patients before and after treatment of clinical symptoms integral changes. Results the total effective rate of the observation group was 95.00%, which was significantly higher than that of the control group (70.00%). There was a significant difference between the two groups (P < 0.05). After treatment, the levels of inflammatory factors TNF - α and IL-10 in the two groups were significantly lower than those before treatment (P < 0.05). The levels of TNF - α and IL-10 in the observation group were significantly lower than those in the control group (P < 0.05). The clinical symptom score of the observation group after treatment was (2.56 ± 0.85), and the difference was statistically significant (P < 0.05). Conclusion mesalazine combined with Bifid Triple Viable Bacteria is effective in the treatment of ulcerative colitis, and can inhibit inflammatory reaction, which is worthy of clinical promotion and application.

简介：[摘 要]目的 探究氢氯吡格雷联合阿司匹林治疗脑梗塞的疗效及对患者日常生活能力改善作用。方法 选2019.01-2020.12接受诊治的126例脑梗塞患者为入选患者，按照计算机随机分配法，分成甲（阿司匹林）、乙（氢氯吡格雷联合阿司匹林）组，各63例。比对、分析两组疗效、神经功能缺损评分及日常生活能力评分。结果 乙组治疗总有效率、日常生活能力评分高于甲组，神经功能缺损评分低于甲组（P

简介：【摘要】目的：分析对于酒精肝胆汁淤积症患者治疗中采用丁二磺酸腺苷蛋氨酸肠溶片联合熊去氧胆酸治疗的临床效果。方法：将2021年5月至2023年12月收治的68例酒精肝胆汁淤积症患者作为研究对象，按照治疗方式进行分组，对照组采取丁二磺酸腺苷蛋氨酸肠溶片进行治疗，试验组在对照组基础上联合熊去氧胆酸。结果：试验组患者治疗有效率高于对照组（97.14%）高于对照组（77.14%）；治疗后，试验组STB、DB、ALT水平均低于对照组（P＜0.05）。结论：对于酒精肝胆汁淤积症患者，采用丁二磺酸腺苷蛋氨酸肠溶片联合熊去氧胆酸进行治疗，临床效果佳，可以改善患者的肝功能。